In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 272437-84-0, name is 3-Oxo-3,4-dihydro-2H-1,4-benzothiazine-6-carboxylic acid, introducing its new discovery. Recommanded Product: 3-Oxo-3,4-dihydro-2H-1,4-benzothiazine-6-carboxylic acid
Tetrahydroindazole inhibitors of bacterial type II topoisomerases. Part 2: SAR development and potency against multidrug-resistant strains
We have previously reported a novel class of tetrahydroindazoles that display potency against a variety of Gram-positive and Gram-negative bacteria, potentially via interaction with type II bacterial topoisomerases. Herein are reported SAR investigations of this new series. Several compounds possessing broad-spectrum potency were prepared. Further, these compounds exhibit activity against multidrug-resistant Gram-positive microorganisms equivalent to that against susceptible strains.
Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.Recommanded Product: 3-Oxo-3,4-dihydro-2H-1,4-benzothiazine-6-carboxylic acid, you can also check out more blogs aboutRecommanded Product: 3-Oxo-3,4-dihydro-2H-1,4-benzothiazine-6-carboxylic acid
Reference£º
Thiazine – an overview | ScienceDirect Topics,
Thiazine | C4H5NS – PubChem